Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

Market Cap	9.84B +98.3%
Revenue (ttm)	1.39B +8.4%
Net Income	174.86M -16.4%
EPS	1.22 -51.5%
Shares Out	133.64M
PE Ratio	60.13
Forward PE	40.80
Dividend	0.40 (0.54%)
Ex-Dividend Date	Aug 29, 2025

Volume	1,354,450
Average Volume	1,806,470
Open	73.45
Previous Close	73.45
Day's Range	73.22 - 75.85
52-Week Range	31.83 - 110.00
Beta	n/a
RSI	41.45
Earnings Date	Apr 24, 2026

About SHE:301617

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in four segments: Iodine Derivatives, Industrial Catalysts (precious metals), Organosilicon Series, and Chemiluminescent Materials. The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodate, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, tris(dioxa-3,6-h...

• Industry: Industrial Inorganic Chemicals
• Founded: 2008
• Employees: 667
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301617

Financial Performance

In 2024, SHE:301617's revenue was 1.33 billion, an increase of 29.53% compared to the previous year's 1.03 billion. Earnings were 213.13 million, an increase of 17.04%.